Surface-tailoring of emulsomes for boosting brain delivery of vinpocetine via intranasal route: in vitro optimization and in vivo pharmacokinetic assessment
暂无分享,去创建一个
F. Caraci | Giuseppe Caruso | N. Alhakamy | S. M. Badr-Eldin | H. Aldawsari | A. Privitera | Nourah Y Assiri
[1] Chen Jiang,et al. Brain-targeting drug delivery systems. , 2022, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[2] G. Grosso,et al. Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer’s Disease , 2022, Nutrients.
[3] R. Taliyan,et al. Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB , 2021, Pharmaceutics.
[4] G. Grosso,et al. Improving Cognition with Nutraceuticals Targeting TGF-β1 Signaling , 2021, Antioxidants.
[5] O. Ahmed,et al. RETRACTED: Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment , 2021, Pharmaceutics.
[6] F. Caraci,et al. The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells , 2020, Pharmaceutics.
[7] F. Caraci,et al. RETRACTED: The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells , 2020, Pharmaceutics.
[8] W. Banks,et al. Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation , 2020, International journal of molecular sciences.
[9] S. Salomone,et al. A New Human Blood–Retinal Barrier Model Based on Endothelial Cells, Pericytes, and Astrocytes , 2020, International journal of molecular sciences.
[10] Yu Nie,et al. Overcoming the Reticuloendothelial System Barrier to Drug Delivery with a "Don't-Eat-Us" Strategy. , 2019, ACS nano.
[11] Han‐Gon Choi,et al. Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives , 2019, Pharmaceutics.
[12] R. Jolivet,et al. Pivotal role of carnosine in the modulation of brain cells activity: Multimodal mechanism of action and therapeutic potential in neurodegenerative disorders , 2019, Progress in Neurobiology.
[13] F. Erdő,et al. Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery , 2019, Scientia Pharmaceutica.
[14] V. Pulgar. Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges , 2019, Front. Neurosci..
[15] P. Wal,et al. Development and Optimization of Liposomes Containing 5 Fluorouracil and Tretinoin for Skin Warts: 32 Experimental Design , 2019 .
[16] O. Ahmed,et al. Intranasal optimized solid lipid nanoparticles loaded in situ gel for enhancing trans-mucosal delivery of simvastatin , 2018, Journal of Drug Delivery Science and Technology.
[17] L. Casettari,et al. A Tailored Thermosensitive PLGA-PEG-PLGA/Emulsomes Composite for Enhanced Oxcarbazepine Brain Delivery via the Nasal Route , 2018, Pharmaceutics.
[18] F. Erdő,et al. Evaluation of intranasal delivery route of drug administration for brain targeting , 2018, Brain Research Bulletin.
[19] A. Marangoni,et al. Molecular Insights into the Eutectic Tripalmitin/Tristearin Binary System. , 2018, Journal of the American Chemical Society.
[20] K. Kontogiannopoulos,et al. Comparative Study of PEGylated and Conventional Liposomes as Carriers for Shikonin , 2018 .
[21] M. R. Mozafari,et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems , 2018, Pharmaceutics.
[22] Miao Liu,et al. The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle. , 2018, Nanomedicine : nanotechnology, biology, and medicine.
[23] Jian-Dong Li,et al. An update on vinpocetine: New discoveries and clinical implications , 2018, European journal of pharmacology.
[24] P. Ho,et al. Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain , 2017, Asian journal of pharmaceutical sciences.
[25] Ghule Mm,et al. Formulation and Evaluation of Modified Liposome for Transdermal Drug , 2018 .
[26] Yingli An,et al. Surface-adaptive zwitterionic nanoparticles for prolonged blood circulation time and enhanced cellular uptake in tumor cells. , 2018, Acta biomaterialia.
[27] Mengrui Liu,et al. Progress in brain targeting drug delivery system by nasal route , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[28] P. Ho,et al. Intranasal administration of brain‐targeted HP‐β‐CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia , 2017, The Journal of pharmacy and pharmacology.
[29] S. Shrotriya,et al. In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting , 2017, Drug development and industrial pharmacy.
[30] Eran A Barnoy,et al. The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study. , 2017, Nanomedicine.
[31] I. Tomuță,et al. Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach , 2017, Drug design, development and therapy.
[32] M. Kassem,et al. Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies , 2017, Drug delivery.
[33] P. Upadhyay,et al. Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route , 2016, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[34] M. Samaha,et al. Liposomes as potential carriers for ketorolac ophthalmic delivery: formulation and stability issues , 2017 .
[35] Yongzhuo Huang,et al. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy. , 2016, ACS nano.
[36] D. B. Vieira,et al. Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier , 2016, International journal of nanomedicine.
[37] R. Narayan,et al. Development of risperidone liposomes for brain targeting through intranasal route. , 2016, Life sciences.
[38] L. Ming,et al. Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes , 2016, Pharmaceutics.
[39] P. R. Vuddanda,et al. Trans resveratrol loaded DSPE PEG 2000 coated liposomes: An evidence for prolonged systemic circulation and passive brain targeting , 2016 .
[40] G. Awad,et al. Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies. , 2016, International journal of pharmaceutics.
[41] A. Zidan,et al. Glycosylated Sertraline-Loaded Liposomes for Brain Targeting: QbD Study of Formulation Variabilities and Brain Transport , 2016, AAPS PharmSciTech.
[42] M. Tariq,et al. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil , 2016, Drug design, development and therapy.
[43] A. Zidan,et al. Ultrasound effects on brain-targeting mannosylated liposomes: in vitro and blood–brain barrier transport investigations , 2015, Drug design, development and therapy.
[44] Sayed M. Ahmed,et al. Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study , 2015, Drug design, development and therapy.
[45] Zhipeng Chen,et al. Preparation and performance evaluation of emulsomes as a drug delivery system for silybin , 2015, Archives of pharmacal research.
[46] Shirui Mao,et al. Development and evaluation of vinpocetine inclusion complex for brain targeting , 2015 .
[47] U. Sleytr,et al. Emulsomes Meet S-layer Proteins: An Emerging Targeted Drug Delivery System , 2015, Current pharmaceutical biotechnology.
[48] P. Young,et al. Solid lipid microparticles as an approach to drug delivery , 2015, Expert opinion on drug delivery.
[49] B. Sudhakar,et al. Factorial design studies of antiretroviral drug-loaded stealth liposomal injectable: PEGylation, lyophilization and pharmacokinetic studies , 2015, Applied Nanoscience.
[50] Neeraj Kumar,et al. Neurological disorders. , 2015, World review of nutrition and dietetics.
[51] A. Akbarzadeh,et al. Pegylation of Nanoliposomal Paclitaxel Enhances its Efficacy in Breast Cancer , 2014 .
[52] A. Bunker,et al. Cholesterol level affects surface charge of lipid membranes in saline solution , 2014, Scientific Reports.
[53] Alaa A. Abdul Rassol,et al. FORMULATION AND EVALUATION OF SILIBININ LOADED SOLID LIPID NANOPARTICLES FOR PERORAL USE TARGETING LOWER PART OF GASTROINTESTINAL TRACT , 2014 .
[54] A. M. Carmona-Ribeiro,et al. Cationic Antimicrobial Polymers and Their Assemblies , 2013, International journal of molecular sciences.
[55] Mingyuan Gao,et al. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. , 2012, ACS nano.
[56] A. Pal,et al. RETRACTED ARTICLE Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis , 2012, Journal of liposome research.
[57] G. Betageri,et al. Development and Stability Studies of Novel Liposomal Vancomycin Formulations , 2012, ISRN pharmaceutics.
[58] Qiang Zhang,et al. Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting , 2012, International journal of nanomedicine.
[59] A. Lamprecht,et al. Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I , 2011, Drug development and industrial pharmacy.
[60] Ü. Langel,et al. Cell-Penetrating Peptides , 2000, Methods in Molecular Biology.
[61] Omar K. Shoukry,et al. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[62] S. Patankar,et al. Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. , 2010, Colloids and surfaces. B, Biointerfaces.
[63] N. Seetapan,et al. Nondestructive rheological measurement of aqueous dispersions of solid lipid nanoparticles: effects of lipid types and concentrations on dispersion consistency , 2010, Drug development and industrial pharmacy.
[64] Xin-guo Jiang,et al. Determination of vinpocetine and its primary metabolite, apovincaminic acid, in rat plasma by liquid chromatography-tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[65] Bhumika Pandey,et al. Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Preparation, Characterization, and in Vitro Release Study of Albendazole-encapsulated Nanosize Liposomes , 2022 .
[66] N. Mishra,et al. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. , 2009, International journal of pharmaceutics.
[67] N. Udupa,et al. A study of rivastigmine liposomes for delivery into the brain through intranasal route , 2008, Acta pharmaceutica.
[68] Rania M. Hathout,et al. Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies , 2007, AAPS PharmSciTech.
[69] S. Vyas,et al. Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting , 2007, Journal of drug targeting.
[70] Sergio L. Schmukler,et al. Emerging Market Instability : Do Sovereign Ratings Affect Country Risk and Stock Returns ? , 1997 .
[71] Sanyog Jain,et al. Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver , 2006, The Journal of pharmacy and pharmacology.
[72] Mohan G. Hebsur,et al. Development and Characterization , 1998 .
[73] S. Gad. Intranasal Administration , 1994 .